Search for: "Sanofi-Aventis, U.S., Inc." Results 81 - 100 of 120
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2009, 2:36 pm
The last big pharmaceutical industry acquisition came in August 2004, when Paris-based Sanofi-Synthelabo acquired Aventis SA of Strasburg, France, for $64.4 billion to create Sanofi Aventis SA, France's largest drugmaker. [read post]
18 Feb 2011, 11:47 am by Sheppard Mullin
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
25 Jul 2013, 11:43 am by Dennis Crouch
Lucier was a thalidomide case against GSK, SmithKline Beecham, Sanofi-Aventis, Grunethal, and others and was originally filed in Pennsylvania state court. [read post]
23 Nov 2011, 1:13 pm by Tom Lamb
Sanofi-aventis Canada Inc., in collaboration with Health Canada, would like to inform patients of important safety information related to the use of the heart drug Multaq (dronedarone).... (12/13/11) ______________________________________________________________________________ In mid-June 2011 drug regulators first turned their attention to cardiovascular side effects associated with the use of Multaq (dronedarone), soon after Sanofi announced that it… [read post]
15 May 2011, 2:54 pm by FDABlog HPM
Karst –       Last week, the Federal Trade Commission (“FTC”) announced that the Commission’s Bureau of Competition (“Bureau”) sent letters (here, here, and here) to Sanofi-Aventis U.S. [read post]
10 Jun 2010, 3:58 am
Kappos (Patent Docs)   Products Allegra (Fexofenadine) - US: Patent infringement complaint following a Paragraph IV certification: Sanofi-Aventis U.S. [read post]
29 Jun 2011, 3:34 am by Marie Louise
Cipla (Spicy IP) Effexor (Venlafaxine) – US: Intellipharmaceutics announces settlement for its generic version of Effexor (GenericsWeb) Eloxatin (Oxaliplatin) – US: Patent infringement complaint in response to Para IV certification: Sanofi-Aventis U.S. [read post]
” Here, the State of West Virginia, by its Attorney General alleged that the defendants Bristol-Meyers Squibb Company, Sanofi-Aventis U.S., LLC, Sanofi U.S. [read post]
10 Jul 2011, 11:29 pm by Gordon Johnson
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
10 May 2012, 7:45 am
  A Sanofi Aventis scientist has been sentenced to 18 months in prison for stealing the pharmaceutical company's trade secrets and putting them up for sale through the U.S. branch of a Chinese chemicals company. [read post]
25 Jun 2010, 1:28 pm by Tom Lamb
We start with a June 24, 2010 Wall Street Journal article, "WellPoint's Data Led It To Limit Use Of Drug Boniva Article", from we learn that the largest U.S. managed care business in terms of membership, WellPoint Inc., has found through internal research that the osteoporosis drug Boniva, which is marketed by Roche Holding AG's Genentech and GlaxoSmithKline PLC, is linked to higher fracture rates than two other bisphosphonates, Actonel, marketed by… [read post]